Earnings History Data for ReShape Lifesciences, Inc. (RSLS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ReShape Lifesciences, Inc.

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
15-05-2024 AH RSLS ReShape Lifesciences, Inc. 3.92 -0.09 0.00 -1.56 ReShape Lifesciences reports Q1 results
[5/15/2024 5:02 PM]
0.1712 0.0 
(-1.61%)
0.17 0.0 
(-2.36%)
0.14 - 2.76 458,461 190,000 10,516
08-11-2023 AH RSLS ReShape Lifesciences, Inc. 0.82 -1.02 0.00 -10.50 ReShape Lifesciences reports Q3 results
[11/8/2023 5:45 PM]
0.2346 -0.02 
(-7.60%)
0.24 -0.01 
(-5.47%)
0.19 - 22.40 1,238,862 1,780,000 76,809
15-05-2023 AH After the close
(May 15)
RSLS ReShape Lifesciences, Inc. 4.32 -1.56 0.00 21.00 ReShape Lifesciences reports Q1 results
[5/15/2023 4:20 PM]
2.30 -0.16 
(-6.50%)
2.43 -0.03 
(-1.22%)
2.21 - 52.50 75,270 100,000 2,965
14-11-2022 PM 0:00 AM ET
(Nov 14)
RSLS ReShape Lifesciences, Inc. 3.50 -0.21 0.00 -1.20 ReShape Lifesciences reports Q3 results
[11/14/2022 7:37 AM]
0.24 0.01 
(3.18%)
0.25 0.01 
(6.19%)
0.20 - 2.33 257,621 180,000 12,257
23-05-2022 PM 0:00 AM ET
(May 23)
RSLS ReShape Lifesciences, Inc. 15.48 -0.42 0.00 -1.32 ReShape Lifesciences GAAP EPS of -$0.44 misses by $0.10, revenue of $2.44M misses by $0.78M
[5/23/2022 8:02 AM]
0.8015 -0.01 
(-1.78%)
0.81 -0.01 
(-0.74%)
0.65 - 14.64 39,520 70,000 4,884
28-03-2022 AH 0:00 AM ET
(Mar 28)
RSLS ReShape Lifesciences, Inc. 20.28 0.05 0.00 -0.51 ReShape Lifesciences GAAP EPS of $5.00, revenue of $13.69M
[3/28/2022 4:11 PM]
1.37 0.02 
(1.33%)
1.52 0.17 
(12.59%)
0.83 - 14.64 520,982 260,000 69,633
11-11-2021 PM Before the open
(Nov 11)
RSLS ReShape Lifesciences, Inc. 42.30 -1.20 0.00 -0.60 ReShape Lifesciences reports Q3 results
[11/11/2021 8:54 AM]
2.47 -0.05 
(-2.17%)
2.52 -0.01 
(-0.40%)
2.38 - 32.31 901,453 440,000 73,365
05-08-2021 PM RSLS ReShape Lifesciences, Inc. 58.93 N/A 0.00 -1.62 ReShape Lifesciences reports Q2 results
[8/5/2021 8:47 AM]
3.85 0.25 
(6.89%)
3.99 0.39 
(10.83%)
2.13 - 32.31 3,878,720 3,240,000 2,082,133